黑龙江科学2024,Vol.15Issue(8) :118-120.

重组鲎C因子(rFC)替代鲎血制备鲎试剂的研究进展

Research Progress of Recombinant Limulus C Factor(rFC)Replacing Limulus Blood in Preparation of Limulus Reagents

杨绍宇 温芝婷 荣冬颖 卢楚群 罗杰雄 王红
黑龙江科学2024,Vol.15Issue(8) :118-120.

重组鲎C因子(rFC)替代鲎血制备鲎试剂的研究进展

Research Progress of Recombinant Limulus C Factor(rFC)Replacing Limulus Blood in Preparation of Limulus Reagents

杨绍宇 1温芝婷 1荣冬颖 1卢楚群 1罗杰雄 1王红1
扫码查看

作者信息

  • 1. 北部湾大学海洋学院,广西钦州 535000
  • 折叠

摘要

鲎试剂广泛用于检测医药产品中的细菌内毒素,但由于鲎资源稀缺,制约了鲎试剂的生产.重组鲎C因子(rFC)作为鲎试剂的替代品,通过基因工程表达获得,可特异性检测内毒素,不依赖动物资源.综述了 rFC的检测机制、发展历程及药典认可情况.研究表明,rFC方法具有特异性强、不依赖动物资源等优点,已渐被药典认可,是解决鲎试剂供应短缺的可靠方案,具有重要的应用前景.

Abstract

Limulus reagents are widely used to detect bacterial endotoxins in pharmaceutical products,but the production of limulus reagents is restricted due to the scarcity of limulus resources.As a substitute for limulus reagents,recombinant limulus C factor(rFC)can be obtained by gene engineering and can specifically detect endotoxins without dependence on animal resources.The study reviews the detection mechanism,development history and pharmacopoeia approval of rFC.Studies have shown that rFC method has the advantages of strong specificity and independent of animal resources,and has been gradually recognized by pharmacopoeia as a reliable solution to solve the shortage of limulus reagents.It has important application prospects.

关键词

鲎C因子/基因工程/鲎试剂/药典

Key words

Limulus C factor/Genetic engineering/Tachypleus Amebocyte Lysate/Pharmacopeia

引用本文复制引用

基金项目

国家自然科学基金(42266004)

广西壮族自治区高等学校中青年教师科研基础能力提升项目(2020KY10011)

出版年

2024
黑龙江科学
黑龙江省科学院

黑龙江科学

影响因子:1.014
ISSN:1674-8646
参考文献量7
段落导航相关论文